Physician

Chad Joseph Cooper, M.D.

According to 2025 Medicare claims, Chad Cooper, M.D. (NPI: 1770876229) practices gastroenterology in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is GASTROENTEROLOGY ASSOCIATES, LLC (NPI: 1811909807; TIN: 830237511) and primary practice location at 82601-1337. Cooper is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Cooper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 727 traditional Medicare patients, billed 3,104 HCPCS/CPT codes, and received $178,261 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 2,027 prescription claims across 574 beneficiaries totaling $1,066,715 in drug costs, led by Stelara (Ustekinumab). 2018 DME data shows 22 claims. Open Payments data shows 18 records totaling $448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,677 to $178,261. Similarly, Part D prescription costs have risen steadily, from $33,179 to $1,066,715. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	114	115	$16,677
2017	114	114	$14,180
2018	49	50	$6,656
2019	173	402	$37,693
2020	393	1,058	$104,077
2021	524	2,314	$157,966
2022	572	1,511	$129,998
2023	744	2,123	$166,517
2024	727	3,104	$178,261

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	321	$33,179
2016	N/R	14	$766
2017	36	78	$14,109
2018	52	124	$33,205
2019	101	167	$16,724
2020	189	549	$47,644
2021	293	802	$539,227
2022	319	976	$555,942
2023	509	1,733	$839,176
2024	574	2,027	$1,066,715

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$919
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	213	215	$108
43249	Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm	125	128	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	111	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	183	$57
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	341	350	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	20	728	$609,645
Creon	Lipase/Protease/Amylase	71	3,140	$107,995
Linzess	Linaclotide	40	2,610	$42,611
Pantoprazole Sodium	Pantoprazole Sodium	1,026	82,740	$15,795
Mesalamine	Mesalamine	16	1,080	$12,050

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$448	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chad Joseph Cooper, M.D.?

Tedicare shows public-source Medicare data for Chad Joseph Cooper, M.D. (NPI 1770876229), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chad Joseph Cooper, M.D. have ACO affiliation data?

Chad Joseph Cooper, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Chad Joseph Cooper, M.D.?

Chad Joseph Cooper, M.D. is linked to GASTROENTEROLOGY ASSOCIATES, LLC (billing NPI 1811909807) in the available physician profile data.

Does Chad Joseph Cooper, M.D. have Open Payments data?

Chad Joseph Cooper, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.